Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Multiplex PCR Assays Market’s size between 2026 and 2030?
The multiplex pcr assays market has experienced rapid expansion in recent years. It is projected to increase from $1.7 billion in 2025 to $1.93 billion in 2026, at a compound annual growth rate (CAGR) of 13.4%. The expansion observed in the past can be linked to the escalating prevalence of infectious diseases, the growing integration of molecular diagnostics, the constraints of singleplex PCR testing, the heightened need for prompt diagnostic outcomes, and the broadening of diagnostic laboratory infrastructure.
The multiplex pcr assays market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $3.17 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.2%. Key drivers for this growth during the projected period include an increased emphasis on detecting diseases early, a heightened need for extensive diagnostic solutions, the broadening application of personalized medicine strategies, greater capital allocation to molecular diagnostics, and the wider integration of multiplex assays into standard testing procedures. Significant trends anticipated for the forecast timeframe encompass the expanding utilization of multiplex testing for infectious conditions, a surging requirement for high-throughput diagnostic tests, the increasing deployment of syndromic testing panels, the broadening scope of multiplex pcr within clinical diagnostics, and a growing inclination towards economical multi-target assays.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp
Which Drivers Are Shaping Strategic Decisions In The Multiplex PCR Assays Market?
The expanding need for diagnostic examinations is projected to drive the future expansion of the multiplex PCR assay market. These tests or procedures are utilized to ascertain if a patient has a particular illness or health issue. The growing need for such testing stems from the rise in chronic conditions such as cancer and diabetes, necessitating prompt and precise diagnosis for successful treatment. Furthermore, an emphasis on proactive health management promotes consistent screening to identify problems at an early stage. Multiplex PCR assays enable the concurrent identification and examination of numerous pathogens or genetic markers from one sample, thereby improving the effectiveness and thoroughness of diagnostic testing. As an illustration, in July 2024, the National Health Service (NHS), a U.K.-based hospital and healthcare provider, reported that diagnostic procedures surpassed pre-pandemic volumes in 2023, with diagnostic tests showing a 21% rise in May 2024 over 2023, totaling 2.4 million tests performed that month. Consequently, the heightened demand for diagnostic testing is set to fuel the growth of the multiplex PCR assay market.
What Segment Classifications Make Up The Multiplex PCR Assays Market?
The multiplex pcr assays market covered in this report is segmented –
1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays
Which Trends Are Influencing The Performance And Direction Of The Multiplex PCR Assays Market?
Leading companies operating within the multiplex PCR assays market are increasingly focusing on incorporating automation, such as next-generation quantitative PCR (qPCR) systems. This integration aims to deliver precise and adaptable nucleic acid quantification essential for advanced clinical diagnostics and public health. Next-generation qPCR systems enable high-throughput, accurate, and simultaneous detection of multiple targets, thereby enhancing diagnostic accuracy and efficiency. For example, in November 2023, Roche Diagnostics Corporation, a Switzerland-based diagnostic system solutions manufacturer, introduced the LightCycler PRO System. This next-generation qPCR platform provides high-throughput, precise, and concurrent detection of multiple targets. It incorporates improved temperature uniformity, sophisticated software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, leading to better diagnostic accuracy and efficiency. This system exemplifies the integration of automation within the multiplex PCR assays market, driving progress in clinical diagnostics and public health.
Which Major Firms Are Strengthening Their Position In The Multiplex PCR Assays Market?
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report
Which Global Regions Are Shaping The Competitive Landscape Of The Multiplex PCR Assays Market?
North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Multiplex PCR Assays Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp
Browse Through More Reports Similar to the Global Multiplex PCR Assays Market 2026, By The Business Research Company
Multiplex Assays Market 2026
https://www.thebusinessresearchcompany.com/report/multiplex-assays-market
Polymerase Chain Reaction Pcr Technologies Global Market Report 2026
Multiplex Biomarker Imaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company